Published in Biotech Business Week, March 13th, 2006
In November 2003, IMT was granted the exclusive worldwide rights to manufacture, sell and distribute and sublicense products relating to the technology and associated patents for use in the treatment of sexual dysfunction by Sheiman Ultrasonic Research Foundation....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.